Pfizer teams helps Fudan University found clinical data management MSc

- Last updated on GMT

US pharmaceutical giant Pfizer has teamed up with China’s Fudan University to set up a Master’s degree programme in clinical data management and statistical programming.

The three-year course, which will be available to this September’s graduate intake, will focus on biostatistics, clinical sciences, clinical project management and pharmacovigilence.

Pfizer will offer students the chance to gain industry experience on various clinical projects. The firm also plans to provide $500,000 a year for the next three years to basic research conducted at the nearby Shanghai Institute of Biological Sciences (SIBS).

Professor Shaode Qin, Fudan University’s Chancellor, told Seeking Alpha​ that the ultimate aim of the partnership is to found a drug research and development centre at the university to teach the next generation of pharmaceutical scientists and engineers.

Related news

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers